PT1021184E - Utilizacao de flunarizina para o tratamento topico da hipertensao ocular - Google Patents

Utilizacao de flunarizina para o tratamento topico da hipertensao ocular

Info

Publication number
PT1021184E
PT1021184E PT98950292T PT98950292T PT1021184E PT 1021184 E PT1021184 E PT 1021184E PT 98950292 T PT98950292 T PT 98950292T PT 98950292 T PT98950292 T PT 98950292T PT 1021184 E PT1021184 E PT 1021184E
Authority
PT
Portugal
Prior art keywords
flunarizine
flunarizin
utilization
topical treatment
glaucoma
Prior art date
Application number
PT98950292T
Other languages
English (en)
Inventor
Lisi Giuseppe
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of PT1021184E publication Critical patent/PT1021184E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT98950292T 1997-10-10 1998-10-06 Utilizacao de flunarizina para o tratamento topico da hipertensao ocular PT1021184E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000613A IT1295423B1 (it) 1997-10-10 1997-10-10 Uso della flunarizina nella terapia topica del glaucoma

Publications (1)

Publication Number Publication Date
PT1021184E true PT1021184E (pt) 2005-06-30

Family

ID=11405290

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98950292T PT1021184E (pt) 1997-10-10 1998-10-06 Utilizacao de flunarizina para o tratamento topico da hipertensao ocular

Country Status (16)

Country Link
US (1) US6380198B1 (pt)
EP (1) EP1021184B1 (pt)
JP (1) JP4475802B2 (pt)
AT (1) ATE289198T1 (pt)
AU (1) AU734137B2 (pt)
BR (1) BR9813855A (pt)
CA (1) CA2306371C (pt)
CZ (1) CZ294314B6 (pt)
DE (1) DE69829062T2 (pt)
ES (1) ES2237852T3 (pt)
HU (1) HU227940B1 (pt)
IT (1) IT1295423B1 (pt)
PL (1) PL192217B1 (pt)
PT (1) PT1021184E (pt)
SK (1) SK285200B6 (pt)
WO (1) WO1999018963A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398900A1 (en) * 2000-01-31 2001-08-09 Santen Pharmaceutical Co., Ltd. Therapeutic agents for opthalmopathy
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
CA2629065C (en) * 2005-12-22 2013-08-06 Newron Pharmaceuticals S.P.A. 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
WO2007076358A1 (en) * 2005-12-23 2007-07-05 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
DK2723710T3 (en) 2011-06-27 2016-11-21 Newron Pharm Spa Flour ready arylalkylaminocarboxamidderivater

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023082A1 (en) * 1992-05-13 1993-11-25 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Also Published As

Publication number Publication date
ES2237852T3 (es) 2005-08-01
SK4992000A3 (en) 2000-12-11
ITRM970613A1 (it) 1999-04-10
HU227940B1 (hu) 2012-06-28
JP4475802B2 (ja) 2010-06-09
AU9643398A (en) 1999-05-03
JP2001519394A (ja) 2001-10-23
AU734137B2 (en) 2001-06-07
CA2306371A1 (en) 1999-04-22
EP1021184B1 (en) 2005-02-16
HUP0003803A2 (hu) 2001-05-28
PL192217B1 (pl) 2006-09-29
SK285200B6 (sk) 2006-08-03
BR9813855A (pt) 2000-09-19
WO1999018963A1 (en) 1999-04-22
IT1295423B1 (it) 1999-05-12
DE69829062D1 (de) 2005-03-24
ATE289198T1 (de) 2005-03-15
HUP0003803A3 (en) 2001-12-28
DE69829062T2 (de) 2006-02-09
CZ20001213A3 (cs) 2000-07-12
EP1021184A1 (en) 2000-07-26
CA2306371C (en) 2008-12-02
PL339453A1 (en) 2000-12-18
CZ294314B6 (cs) 2004-11-10
US6380198B1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
CA2125060A1 (en) Ophthalmic Solution for Artificial Tears
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
EP1514548A3 (en) Use of cloprostenol fluprostenol, and their analogues to treat glaucoma and ocular hypertension
ES2062102T3 (es) Derivados de prostaglandinas para el tratamiento de glaucoma o hipertension ocular.
ES2182973T3 (es) Metodo para reducir la presion intraocular enel ojo de mamifero por administracion de bloqueadors de canal de potasio.
EP0879601A3 (en) Ophthalmic drug delivery system
IE811654L (en) Ophthalmic composition
PT1021184E (pt) Utilizacao de flunarizina para o tratamento topico da hipertensao ocular
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
ATE223200T1 (de) Einen carboanhydrase-hemmer und xanthangummi enthaltendes augenarzneimittel
DE69705421D1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
HK1024170A1 (en) Remedial composition for intraocular hypertension or glaucoma
DE69323202D1 (de) Ophthalmologische zubereitungen
AU2001278708A1 (en) Adenosine derivatives and use thereof
DK0403360T3 (da) Anvendelse af phenylethanolaminer til fremstilling af et lægemiddel mod øjenlidelser
SE9401087D0 (sv) New prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
WO2003011299A3 (en) Treatment of ocular hypertension and glaucoma
WO2002040030A8 (en) Combination therapy for lowering and controlling intraocular pressure
PT1186302E (pt) Composicao para fazer descer a tensao ocular para administracao topica
CA2240271A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
BR9901566A (pt) Análogos cis-delta4 de prostaglandinas como hipotensores oculares
CA2219280A1 (en) Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers